September 24, 2026

Insurers argue that MedPAC's estimate, which is broadly cited by members of Congress, health policy experts and other stakeholders in the healthcare industry, is flawed and makes MA seem costlier than it really is. MA plans instead prefer a CMS analysis from January that yields a dramatically lower estimate of overpayments, or industry-funded research that finds MA is actually cheaper for taxpayers.

While robotic surgery has entered the mainstream, with pioneer Intuitive's systems supporting more than 20 million surgeries since the company's founding three decades ago, telerobotic surgery remains in its infancy. It is estimated that roughly 5,000 remote surgeries have been performed around the world to date.

While the CMS emphasizes its commitment to ensuring Medicare Advantage plans deliver quality care while stewarding taxpayer dollars responsibly, the stakes are significant. MA plans have drawn mounting criticism for costing substantially more than traditional Medicare, limiting access through restrictive provider networks and prior authorization requirements. Yet regulators face a delicate balancing act: responding to voter demands for lower healthcare costs while avoiding conflict with Republicans' traditionally industry-friendly stance.

The immediate moratorium bars new agents and brokers from registering ahead of November's open enrollment, while the administration simultaneously terminates coverage for over 760,000 people deemed unauthorized enrollees. Though fraud prevention is a legitimate concern, the measures create a tension: limiting bad actors in the market while potentially constraining capacity and locking out legitimate brokers during a critical enrollment window.

A new Blue Cross Blue Shield Association analysis argues that hospitals' use of AI-powered coding tools is increasing Medicare reimbursement without corresponding improvements in patient care, estimating nearly $1 billion in additional costs for similar services. The findings add to ongoing scrutiny of how AI is being used in clinical documentation and billing, raising questions about payment integrity, oversight, and the appropriate role of automation in healthcare reimbursement.